We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: yes
Payment Terms: L/C
This product is an aminoglycoside antibacterial drug. The injection is suitable for severe infections caused by sensitive Gram-negative bacilli and staphylococcus (methicillin-sensitive strains), such as bacteremia or septicemia, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complex urinary tract infection, skin and soft tissue infection, etc. Because it is stable to most aminoglycoside inactivating enzymes, it is especially suitable for the treatment of severe infections caused by kanamycin, gentamicin or tobramycin resistant strains of gram-negative bacilli. External use for severe traumatic infection caused by sensitive bacteria; Ophthalmic use is suitable for conjunctivitis and keratitis caused by sensitive bacteria.Amikacin mainly acts on the ribosomes in bacteria, inhibits bacterial protein synthesis, and destroys the integrity of bacterial cell walls, resulting in the destruction of bacterial cell membranes and cell death.